South Eastern Sydney Local Health District Drug and Alcohol Service, Sydney, Australia.
Drug Alcohol Rev. 2014 Jan;33(1):33-42. doi: 10.1111/dar.12083. Epub 2013 Nov 11.
The measurement of clinical outcomes is an important, but lacking, component of drug and alcohol treatment in Australia. This study aimed to psychometrically validate the Treatment Outcomes Profile under Australian conditions, examining implementation and feasibility issues in three public opioid treatment program clinics in NSW.
The Treatment Outcomes Profile was modified to reflect Australian conditions and re-named the Australian Treatment Outcomes Profile (ATOP). The ATOP was introduced into the participating clinics and administered by clinic staff at 3-month intervals as part of routine clinical practice. Participants completed a research interview, consisting of the ATOP and a suite of 'gold standard' instruments assessing substance use and related health and welfare domains, in the 72 h following completion of a routine clinical ATOP. The researcher- and clinician-administered ATOPs were compared to assess interrater reliability, and the researcher-administered ATOP and 'gold standard' instruments were compared to assess concurrent validity. Implementation and feasibility issues were assessed using questionnaires and focus groups with clinician and clients.
The ATOP demonstrated acceptable concurrent validity and interrater reliability. It was well received by clients and clinicians, particularly for its ease of use, applicability and brevity.
The ATOP is a psychometrically valid instrument for the measurement of treatment outcomes in Australian opioid treatment populations and can feasibly be implemented as part of routine clinical practice in specialist opioid treatment program clinics. The role of the ATOP to measure outcomes in other drug and alcohol treatment modalities requires exploration.
在澳大利亚，药物和酒精治疗中衡量临床结果是一个重要但欠缺的部分。本研究旨在对澳大利亚条件下的治疗结果概况（Treatment Outcomes Profile）进行心理测量学验证，在新南威尔士州的三个公共阿片类药物治疗计划诊所中检查实施和可行性问题。
对治疗结果概况进行了修改，以反映澳大利亚的情况，并将其重新命名为澳大利亚治疗结果概况（Australian Treatment Outcomes Profile，ATOP）。ATOP 被引入参与的诊所，并由诊所工作人员在 3 个月的间隔内作为常规临床实践的一部分进行管理。参与者在完成常规临床 ATOP 的 72 小时内，完成了研究访谈，包括 ATOP 和一套评估物质使用及相关健康和福利领域的“黄金标准”工具。研究者和临床医生管理的 ATOP 进行了比较，以评估评分者间的可靠性，研究者管理的 ATOP 和“黄金标准”工具进行了比较，以评估同时效度。使用问卷和与临床医生和客户的焦点小组评估实施和可行性问题。
ATOP 表现出可接受的同时效度和评分者间的可靠性。它受到了客户和临床医生的好评，特别是因为它易于使用、适用性和简洁性。
ATOP 是一种在澳大利亚阿片类药物治疗人群中测量治疗结果的心理测量学有效工具，并且可以作为专科阿片类药物治疗计划诊所常规临床实践的一部分进行实施。ATOP 在测量其他药物和酒精治疗方式的结果方面的作用需要进一步探讨。
